Evidence for Multiple Origins of De Novo Formed Vascular Smooth Muscle Cells in Pulmonary Hypertension: Challenging the Dominant Model of Pre-Existing Smooth Muscle Expansion.
Xuran ChuNegah AhmadvandJin-San ZhangWerner SeegerSaverio BellusciElie El AghaPublished in: International journal of environmental research and public health (2021)
Vascular remodeling is a prominent feature of pulmonary hypertension. This process involves increased muscularization of already muscularized vessels as well as neo-muscularization of non-muscularized vessels. The cell-of-origin of the newly formed vascular smooth muscle cells has been a subject of intense debate in recent years. Identifying these cells may have important clinical implications since it opens the door for attempts to therapeutically target the progenitor cells and/or reverse the differentiation of their progeny. In this context, the dominant model is that these cells derive from pre-existing smooth muscle cells that are activated in response to injury. In this mini review, we present the evidence that is in favor of this model and, at the same time, highlight other studies indicating that there are alternative cellular sources of vascular smooth muscle cells in pulmonary vascular remodeling.
Keyphrases
- vascular smooth muscle cells
- pulmonary hypertension
- angiotensin ii
- induced apoptosis
- smooth muscle
- cell cycle arrest
- pulmonary artery
- pulmonary arterial hypertension
- machine learning
- single cell
- endoplasmic reticulum stress
- signaling pathway
- oxidative stress
- cell therapy
- drinking water
- deep learning
- cell proliferation
- pi k akt